Search Results - "Yongblah, Francis"
-
1
FcMBL magnetic bead-based MALDI-TOF MS rapidly identifies paediatric blood stream infections from positive blood cultures
Published in PloS one (22-11-2022)“…Rapid identification of potentially life-threatening blood stream infections (BSI) improves clinical outcomes, yet conventional blood culture (BC)…”
Get full text
Journal Article -
2
FcMBL magnetic bead-based MALDI-TOF MS rapidly identifies paediatric blood stream infections from positive blood cultures
Published in PloS one (22-11-2022)“…Rapid identification of potentially life-threatening blood stream infections (BSI) improves clinical outcomes, yet conventional blood culture (BC)…”
Get full text
Journal Article -
3
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Published in The Lancet (British edition) (28-01-2023)“…The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral antiviral medication for SARS-CoV-2, has not been established in vaccinated patients…”
Get full text
Journal Article -
4
Clostridioides difficile detection and infection in children: are they just small adults?
Published in Journal of medical microbiology (01-03-2024)“…is a well-recognized healthcare-associated pathogen, with its significance widely recognized in adult populations. Despite this, there is limited data on the…”
Get more information
Journal Article -
5
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Published in Nature communications (23-02-2024)“…Viral clearance, antibody response and the mutagenic effect of molnupiravir has not been elucidated in at-risk populations. Non-hospitalised participants…”
Get full text
Journal Article -
6
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Published in The Lancet infectious diseases (09-09-2024)“…No randomised controlled trials have yet reported on the effectiveness of molnupiravir on longer term outcomes for COVID-19. The PANORAMIC trial found…”
Get full text
Journal Article